Early detection of Alzheimer’s disease with a total score of the German CERAD
- 4 August 2010
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 16 (5), 910-920
- https://doi.org/10.1017/s1355617710000822
Abstract
The goal of the present study was to evaluate the diagnostic discriminability of three different global scores for the German version of the Consortium to Establish a Registry on Alzheimer’s Disease-Neuropsychological Assessment Battery (CERAD-NAB). The CERAD-NAB was administered to 1100 healthy control participants [NC; Mini-Mental State Examination (MMSE) mean = 28.9] and 352 patients with very mild Alzheimer’s disease (AD; MMSE mean = 26.1) at baseline and subsets of participants at follow-up an average of 2.4 (NC) and 1.2 (AD) years later. We calculated the following global scores: Chandler et al.’s (2005) score (summed raw scores), logistic regression on principal components analysis scores (PCA-LR), and logistic regression on demographically corrected CERAD-NAB variables (LR). Correct classification rates (CCR) were compared with areas under the receiver operating characteristics curves (AUC). The CCR of the LR score (AUC = .976) exceeded that of the PCA-LR, while the PCA-LR (AUC = .968) and Chandler (AUC = .968) scores performed comparably. Retest data improved the CCR of the PCA-LR and Chandler (trend) scores. Thus, for the German CERAD-NAB, Chandler et al.’s total score provided an effective global measure of cognitive functioning, whereby the inclusion of retest data tended to improve correct classification of individual cases. (JINS, 2010, 16, 910–920.)Keywords
This publication has 28 references indexed in Scilit:
- PET imaging of amyloid deposition in patients with mild cognitive impairmentNeurobiology of Aging, 2008
- Revising the ADAS-cog for a More Accurate Assessment of Cognitive ImpairmentAlzheimer Disease & Associated Disorders, 2008
- Evaluation of diagnostic scores with adjustment for covariatesStatistics in Medicine, 2007
- Lack of Practice Effects on Neuropsychological Tests as Early Cognitive Markers of Alzheimer Disease?American Journal of Alzheimer's Disease and Other Dementias®, 2007
- Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2005
- A total score for the CERAD neuropsychological batteryNeurology, 2005
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological batteryNeurology, 1994
- Detection and Staging of Dementia in Alzheimer's DiseaseArchives of Neurology, 1992
- Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological MeasuresArchives of Neurology, 1991